# A Phase 1 Study of KHN707 Tablets in Healthy Participants

> **NCT07557537** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Chengdu Kanghong Pharmaceutical Group Co., Ltd.** · enrollment: 38 (estimated)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** KHN707 tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07557537
- **Lead sponsor:** Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07557537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07557537, "A Phase 1 Study of KHN707 Tablets in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07557537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*